SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-027006
Filing Date
2020-09-17
Accepted
2020-09-16 20:15:34
Documents
1
Group Members
BEN T. MORRISDON A. SANDERSDONALD V. WEIRJAMES C. GALELIFE SCIENCES OPPORTUNITIES FUND (INSTITUTIONAL) II, L.P.SIGNET HEALTHCARE PARTNERS, LLCSMW INVESTMENTS I, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 TO SCHEDULE 13D ea126557-13da9signet_telige.htm SC 13D/A 152594
  Complete submission text file 0001213900-20-027006.txt   154623
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 856.697.1441
Teligent, Inc. (Subject) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-34057 | Film No.: 201179882
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Business Address 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A